Mechanisms regulating T-cell infiltration and activity in solid tumors
- PMID: 29045511
- DOI: 10.1093/annonc/mdx238
Mechanisms regulating T-cell infiltration and activity in solid tumors
Abstract
T-lymphocytes play a critical role in cancer immunity as evidenced by their presence in resected tumor samples derived from long-surviving patients, and impressive clinical responses to various immunotherapies that reinvigorate them. Indeed, tumors can upregulate a wide array of defense mechanisms, both direct and indirect, to suppress the ability of Tcells to reach the tumor bed and mount curative responses upon infiltration. In addition, patient and tumor genetics, previous antigenic experience, and the microbiome, are all important factors in shaping the T-cell repertoire and sensitivity to immunotherapy. Here, we review the mechanisms that regulate T-cell homing, infiltration, and activity within the solid tumor bed. Finally, we summarize different immunotherapies and combinatorial treatment strategies that enable the immune system to overcome barriers for enhanced tumor control and improved patient outcome.
Keywords: T cells; cancer; immunotherapy; tumor microenvironment.
© The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Similar articles
-
Pushing Past the Blockade: Advancements in T Cell-Based Cancer Immunotherapies.Front Immunol. 2021 Nov 18;12:777073. doi: 10.3389/fimmu.2021.777073. eCollection 2021. Front Immunol. 2021. PMID: 34868044 Free PMC article. Review.
-
Vascular Microenvironment, Tumor Immunity and Immunotherapy.Front Immunol. 2021 Dec 20;12:811485. doi: 10.3389/fimmu.2021.811485. eCollection 2021. Front Immunol. 2021. PMID: 34987525 Free PMC article. Review.
-
CAR T Cell Therapy for Solid Tumors.Annu Rev Med. 2017 Jan 14;68:139-152. doi: 10.1146/annurev-med-062315-120245. Epub 2016 Nov 17. Annu Rev Med. 2017. PMID: 27860544 Review.
-
The HIF-1α hypoxia response in tumor-infiltrating T lymphocytes induces functional CD137 (4-1BB) for immunotherapy.Cancer Discov. 2012 Jul;2(7):608-23. doi: 10.1158/2159-8290.CD-11-0314. Epub 2012 Jun 19. Cancer Discov. 2012. PMID: 22719018
-
Tumor-derived factors affecting immune cells.Cytokine Growth Factor Rev. 2017 Aug;36:79-87. doi: 10.1016/j.cytogfr.2017.06.005. Epub 2017 Jun 8. Cytokine Growth Factor Rev. 2017. PMID: 28606733 Review.
Cited by
-
Physiology of chemokines in the cancer microenvironment.Am J Physiol Cell Physiol. 2023 Jan 1;324(1):C167-C182. doi: 10.1152/ajpcell.00151.2022. Epub 2022 Nov 1. Am J Physiol Cell Physiol. 2023. PMID: 36317799 Free PMC article. Review.
-
The CAR macrophage cells, a novel generation of chimeric antigen-based approach against solid tumors.Biomark Res. 2023 Nov 28;11(1):103. doi: 10.1186/s40364-023-00537-x. Biomark Res. 2023. PMID: 38017494 Free PMC article. Review.
-
Defining Melanoma Immune Biomarkers-Desert, Excluded, and Inflamed Subtypes-Using a Gene Expression Classifier Reflecting Intratumoral Immune Response and Stromal Patterns.Biomolecules. 2024 Jan 31;14(2):171. doi: 10.3390/biom14020171. Biomolecules. 2024. PMID: 38397409 Free PMC article.
-
Biology of NSCLC: Interplay between Cancer Cells, Radiation and Tumor Immune Microenvironment.Cancers (Basel). 2021 Feb 12;13(4):775. doi: 10.3390/cancers13040775. Cancers (Basel). 2021. PMID: 33673332 Free PMC article. Review.
-
Rho-associated protein kinase-dependent moesin phosphorylation is required for PD-L1 stabilization in breast cancer.Mol Oncol. 2020 Nov;14(11):2701-2712. doi: 10.1002/1878-0261.12804. Epub 2020 Oct 3. Mol Oncol. 2020. PMID: 32941674 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources